Michael D Onken

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Basal Cell Carcinoma

Circulating Tumor

Oxidative Stress

Top Venues

Science signaling

BMC medical genomics

Clinical cancer research : an official journal of the American Association for Cancer Research

Washington University in Saint Louis

Washington University in Saint Louis (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington University in Saint Louis Nov 01 2012

United States

Associate Professor :: Biochemistry & Molecular Biophysics

Education History

Washington University in Saint Louis

United States

PHD

Publications

Amanda Truong, Jae Hyuk Yoo, Michael T Scherzer, John Michael S Sanchez, Kali J Dale, Conan G Kinsey, Jackson R Richards, Donghan Shin, Phaedra C Ghazi, Michael D Onken, Kendall J Blumer, Shannon J Odelberg, Martin McMahon
Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Michael D Onken, Carol M Makepeace, Kevin M Kaltenbronn, Stanley M Kanai, Tyson D Todd, Shiqi Wang, Thomas J Broekelmann, Prabakar Kumar Rao, John A Cooper, Kendall J Blumer
Targeting nucleotide exchange to inhibit constitutively active G protein α subunits in cancer cells. Science signaling 11 (546) (2018)
Matthew Yen, Zongtai Qi, Xuhua Chen, John A Cooper, Robi D Mitra, Michael D Onken
Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma. BMC medical genomics 11 (1) (2018)